Study: Zoll’s LifeVest covers ICD explantation patients
A new study in the journal Heart Rhythm shows the utility of Zoll Medical‘s LifeVest wearable defibrillator for a subset of patients who don’t start out with the device.
Augmenix wins FDA nod for SpaceOar prostate treatment
FDA clearance in hand, Augmenix is formulating U.S. commercial sales and insurance reimbursement plans for a medical gel designed to help protect the rectum during prostate cancer radiotherapy, CEP John Pedersen told MassDevice.com today.
More CT scanner problems for Philips Healthcare
Royal Philips (NYSE:PHG) subsidiary Philips Healthcare is dealing with a Class II recall of several models of its CT scanners due to a software glitch.
Report: Stryker to open Irish R&D center
Miracor expands in the U.K.
Austria’s Miracor Medical Systems is boosting its presence in the U.K. with a new sales office and 2 clinical trials of its heart attack-treatment device.
FDA deals a setback to Avedro
Avedro yesterday said the FDA wants more data on its corneal cross-linking technology for treating 2 sight-threatening conditions, meaning the Boston-based medical device company is left with a longer U.S. approval timeline.
Uroplasty, Vision-Sciences merge as Cogentix
Orthofix jumps on restated financials, eNeura deal
Stealthy Saphena Medical raises $1.3m
Stealthy Saphena Medical reported raising close to half of a $3 million planned offering toward development of a device designed to harvest veins for coronary artery bypass grafting.
The West Bridgewater, Mass.-based startup disclosed in a recent SEC filing that it has pulled in nearly $1.27 million so far, through the sale of Series B preferred stock.
Bioness launches clinical trial for StimRouter in overactive bladder
Bioness last week said it’s making progress with a Canadian study of its StimRouter neuromodulation device designed to expand the number of conditions for which it can be used for treatment.